DisperSol Technologies, LLC
Quick facts
Marketed products
Phase 2 pipeline
- DST-0509 · Diabetes
DST-0509 is a small molecule that targets the SGLT2 receptor.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about DisperSol Technologies, LLC
What are DisperSol Technologies, LLC's marketed drugs?
Top marketed products include Exjade, Jadenu.
Related
- Exjade · Other
- Jadenu · Other
- Sector hub: All tracked pharma companies